These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 33515601)

  • 21. Antibodies against alpha-synuclein reduce oligomerization in living cells.
    Näsström T; Gonçalves S; Sahlin C; Nordström E; Screpanti Sundquist V; Lannfelt L; Bergström J; Outeiro TF; Ingelsson M
    PLoS One; 2011; 6(10):e27230. PubMed ID: 22073131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct alpha-Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH-SY5Y cells.
    Pantazopoulou M; Brembati V; Kanellidi A; Bousset L; Melki R; Stefanis L
    J Neurochem; 2021 Mar; 156(6):880-896. PubMed ID: 32869336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
    Filippini A; Gennarelli M; Russo I
    Cell Mol Neurobiol; 2019 Mar; 39(2):161-168. PubMed ID: 30637614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein oligomerization increases its effect on promoting NMDA receptor internalization.
    Yu W; Yang W; Li X; Li X; Yu S
    Int J Clin Exp Pathol; 2019; 12(1):87-100. PubMed ID: 31933723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
    Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
    Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors.
    Gustafsson G; Eriksson F; Möller C; da Fonseca TL; Outeiro TF; Lannfelt L; Bergström J; Ingelsson M
    Cell Mol Neurobiol; 2017 Jan; 37(1):121-131. PubMed ID: 26961542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Localization of Alpha-synuclein in the Endocytic Pathway.
    Fakhree MAA; Konings IBM; Kole J; Cambi A; Blum C; Claessens MMAE
    Neuroscience; 2021 Mar; 457():186-195. PubMed ID: 33482328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Alpha-Synuclein Oligomers Formed with the Aminochrome-Glutathione Conjugate Are Not Neurotoxic.
    Huenchuguala S; Sjödin B; Mannervik B; Segura-Aguilar J
    Neurotox Res; 2019 Feb; 35(2):432-440. PubMed ID: 30343424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing the inhibition of α-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP.
    Dong C; Garen CR; Mercier P; Petersen NO; Woodside MT
    Protein Sci; 2019 Sep; 28(9):1690-1702. PubMed ID: 31306510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characteristics and membrane interactions of tandem α-synuclein oligomers.
    Dong C; Hoffmann M; Li X; Wang M; Garen CR; Petersen NO; Woodside MT
    Sci Rep; 2018 Apr; 8(1):6755. PubMed ID: 29712958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis.
    Freeman D; Cedillos R; Choyke S; Lukic Z; McGuire K; Marvin S; Burrage AM; Sudholt S; Rana A; O'Connor C; Wiethoff CM; Campbell EM
    PLoS One; 2013; 8(4):e62143. PubMed ID: 23634225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of Endocytic Pathways for the Internalization of Exosome-Associated Oligomeric Alpha-Synuclein.
    Delenclos M; Trendafilova T; Mahesh D; Baine AM; Moussaud S; Yan IK; Patel T; McLean PJ
    Front Neurosci; 2017; 11():172. PubMed ID: 28424577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrillar α-synuclein toxicity depends on functional lysosomes.
    Guiney SJ; Adlard PA; Lei P; Mawal CH; Bush AI; Finkelstein DI; Ayton S
    J Biol Chem; 2020 Dec; 295(51):17497-17513. PubMed ID: 33453994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
    Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
    Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteolysis of α-synuclein fibrils in the lysosomal pathway limits induction of inclusion pathology.
    Sacino AN; Brooks MM; Chakrabarty P; Saha K; Khoshbouei H; Golde TE; Giasson BI
    J Neurochem; 2017 Feb; 140(4):662-678. PubMed ID: 27424880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic measurements give new insights into lipid membrane permeabilization by α-synuclein oligomers.
    Stöckl M; Claessens MM; Subramaniam V
    Mol Biosyst; 2012 Jan; 8(1):338-45. PubMed ID: 22009045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.
    Roberts RF; Wade-Martins R; Alegre-Abarrategui J
    Brain; 2015 Jun; 138(Pt 6):1642-57. PubMed ID: 25732184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.